Sponsor Pipeline

TaiRx, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05257590 CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma Recruiting
NCT07521852 A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and… HCC - Hepatocellular Carcinoma Recruiting
NCT03600233 Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors Neuroendocrine Tumors Active, Not Recruiting
Phase 1
NCT06143774 Study of TRX-920 for Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
Disease Areas
Liver Cancer (2)
Get alerts when TaiRx, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free